JP2023501814A5 - - Google Patents
Info
- Publication number
- JP2023501814A5 JP2023501814A5 JP2022528544A JP2022528544A JP2023501814A5 JP 2023501814 A5 JP2023501814 A5 JP 2023501814A5 JP 2022528544 A JP2022528544 A JP 2022528544A JP 2022528544 A JP2022528544 A JP 2022528544A JP 2023501814 A5 JP2023501814 A5 JP 2023501814A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2019-0145709 | 2019-11-14 | ||
| KR20190145709 | 2019-11-14 | ||
| PCT/KR2020/015932 WO2021096270A1 (ko) | 2019-11-14 | 2020-11-12 | Ampk 억제기능과 아연항상성 조절기능에 기반한 다발성 경화증 치료용 약학적 조성물 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023501814A JP2023501814A (ja) | 2023-01-19 |
| JP2023501814A5 true JP2023501814A5 (https=) | 2023-04-25 |
| JPWO2021096270A5 JPWO2021096270A5 (https=) | 2023-04-25 |
| JP7398840B2 JP7398840B2 (ja) | 2023-12-15 |
Family
ID=75911395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022528544A Active JP7398840B2 (ja) | 2019-11-14 | 2020-11-12 | Ａｍｐｋ抑制機能と亜鉛恒常性調節機能に基づく多発性硬化症治療用の薬学的組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12343335B2 (https=) |
| EP (1) | EP4066832A4 (https=) |
| JP (1) | JP7398840B2 (https=) |
| KR (1) | KR102770734B1 (https=) |
| CN (1) | CN114929217A (https=) |
| WO (1) | WO2021096270A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4255419A (en) * | 1979-09-27 | 1981-03-10 | Allergan Pharmaceuticals, Inc. | Zinc deficiency in multiple sclerosis |
| JP2006513143A (ja) | 2002-08-29 | 2006-04-20 | アプライド リサーチ システムズ アルス ホールディング ナムローゼ フエンノートシャップ | タンパク質チロシンホスファターゼ阻害剤 |
| GB0915892D0 (en) * | 2009-09-10 | 2009-10-14 | Smithkline Beecham Corp | Compounds |
| KR101324647B1 (ko) | 2010-12-10 | 2013-11-01 | 한국과학기술연구원 | 다발성신경경화증의 치료 또는 예방용 조성물 및 이의 스크리닝 방법 |
| EP2651405A2 (en) | 2010-12-14 | 2013-10-23 | Electrophoretics Limited | Casein kinase 1 (ck1 ) inhibitors |
| EP2685976B1 (en) * | 2011-03-17 | 2017-12-27 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | Quinolone analogs for treating autoimmune diseases |
| CN104059060B (zh) | 2014-05-30 | 2017-08-01 | 西安交通大学 | 一种5‑(1h‑吲哚‑3‑亚甲基)‑1,3‑噻唑烷‑4‑酮类衍生物及其合成方法和应用 |
| KR101911785B1 (ko) | 2016-08-09 | 2018-10-26 | 세종대학교 산학협력단 | Ampk 억제기능에 기반한 뇌졸중 치료용 약학적 조성물 |
-
2020
- 2020-11-12 US US17/776,693 patent/US12343335B2/en active Active
- 2020-11-12 WO PCT/KR2020/015932 patent/WO2021096270A1/ko not_active Ceased
- 2020-11-12 EP EP20887409.9A patent/EP4066832A4/en not_active Withdrawn
- 2020-11-12 CN CN202080093043.2A patent/CN114929217A/zh active Pending
- 2020-11-12 KR KR1020227017186A patent/KR102770734B1/ko active Active
- 2020-11-12 JP JP2022528544A patent/JP7398840B2/ja active Active